JYSB2500083 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2025-03-26 | | Bayer Healthcare LLC | | | view |
JYSB2500081 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2025-03-26 | | Bayer Healthcare LLC | | | view |
JYSB2500082 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2025-03-26 | | Bayer Healthcare LLC | | | view |
JYSB2500023 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2025-02-08 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
JYSB2500024 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2025-02-08 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
JYSB2500025 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2025-02-08 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
JYSB2500026 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2025-02-08 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
JYSB2400251 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-12-04 | | Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG | | | view |
JYSB2400248 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-12-04 | | Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG | | | view |
JYSB2400250 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-12-04 | | Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG | | | view |
JYSB2400249 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-12-04 | | Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG | | | view |
CYSB2400295 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(原10) | Supplementary Application | 2024-11-12 | | SinoCelltech Ltd | | | view |
CYSB2400294 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(原10) | Supplementary Application | 2024-11-12 | | SinoCelltech Ltd | | | view |
JTS2400107 | 注射用培重组人凝血因子VIII | | Lyophilized | Biological Products | Disposable Import Drug Application | 2024-09-25 | | Baxalta Manufacturing Sàrl;Takeda Canada Inc;Takeda (China) International Trading Co Ltd | | | view |
JTS2400110 | 注射用培重组人凝血因子VIII | | Lyophilized | Biological Products | Disposable Import Drug Application | 2024-09-25 | | Baxalta Manufacturing Sàrl;Takeda Canada Inc;Takeda (China) International Trading Co Ltd | | | view |
JTS2400106 | 注射用培重组人凝血因子VIII | | Lyophilized | Biological Products | Disposable Import Drug Application | 2024-09-25 | | Baxalta Manufacturing Sàrl;Takeda Canada Inc;Takeda (China) International Trading Co Ltd | | | view |
JTS2400105 | 注射用培重组人凝血因子VIII | | Lyophilized | Biological Products | Disposable Import Drug Application | 2024-09-25 | | Baxalta Manufacturing Sàrl;Takeda Canada Inc;Takeda (China) International Trading Co Ltd | | | view |
JTS2400104 | 注射用培重组人凝血因子VIII | | Lyophilized | Biological Products | Disposable Import Drug Application | 2024-09-25 | | Baxalta Us Inc;Takeda Canada Inc;Takeda (China) International Trading Co Ltd | | | view |
JTS2400108 | 注射用培重组人凝血因子VIII | | Lyophilized | Biological Products | Disposable Import Drug Application | 2024-09-25 | | Baxalta Manufacturing Sàrl;Takeda Canada Inc;Takeda (China) International Trading Co Ltd | | | view |
JTS2400109 | 注射用培重组人凝血因子VIII | | Lyophilized | Biological Products | Disposable Import Drug Application | 2024-09-25 | | Baxalta Manufacturing Sàrl;Takeda Canada Inc;Takeda (China) International Trading Co Ltd | | | view |